Immunogenicity and safety of anti‐SARS‐CoV‐2 BNT162b2 vaccine in psoriasis patients treated with biologic drugs. - Cristaudo, A.; Graceffa, D.; Pimpinelli, F.; Sperati, F.; Spoletini, G.; Bonifati, C.; Pellini, R.; Lora, V.; Pontone, M.; Di Bella, O.; Bracco, D.; Morrone, A. (Journal of the European Academy of Dermatology & Venereology, 2022)